The role of docetaxel in the multimodal treatment of non-small cell lung cancer

Rita De Sanctis, Igina D’Antoni, Ester Del Signore, Bruno Gori, Flavia Longo

DOI: https://doi.org/10.7175/cmi.v3i2.550

Abstract

We report the case of a 53-year-old woman with brain metastatic Non-Small Cell Lung Cancer (NSCLC). Diagnosis was made during brain surgery. Brain metastases were treated both with surgery and radiotherapy. The chemotherapy schedule was cisplatin 75 mg/m2 and docetaxel 75 mg/m2 1q21 for up to six cycles. Toxicities encountered were easily manageable. Subsequent thoracic radiotherapy improved tumor response and quality of life.

Keywords

Non-Small Cell Lung Cancer; Brain metastases; Concurrent chemoradiotherapy; Docetaxel

Full Text

PDF

Statistics

Abstract: 486 views
PDF: 303 views

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.